Document is current
Any future updates will be listed below
-
Authors
Elia, Clara
de Girolamo, Laura
Clarisse, Bénédicte
Galin, Melvin
Rehel, Stéphane
Clochon, Patrice
Doidy, Franck
Segobin, Shailendra
Viader, Fausto
Naveau, Mikaël
Delcroix, Nicolas
Segura-Djezzar, Carine
Grellard, Jean-Michel
Lequesne, Justine
Etard, Olivier
Martin, Tristan
Quarck, Gaëlle
Eustache, Francis
Joly, Florence
Giffard, Bénédicte
Perrier, Joy
-
Funding
Funding for this research was provided by:
Université de Caen Normandie (Doctoral Contract)
Région Normandie (Chair of excellence 2020)
Fondation ARC pour la Recherche sur le Cancer (ARCPJA2021060003783)
- License Information
-
More Information
Article History
Received: 5 July 2023
Accepted: 21 November 2023
First Online: 1 December 2023
Declarations
:
: This study has received ethical approval from the ethics committee of <i>Comité de Protection des Personnes</i> Ile de France IV on 19th of April 2022 (N° ID-RCB: 2022-A00437-36). Eligible patients will be asked to participate by the medical and/or radiation oncologists, and eligible women free of disease will be asked to participate by the physicians from the U1077 University team. All eligible participants (patients and healthy women) will receive an information file. All participants will give their informed consent before any study-related assessment starts. All methods will be performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.
